门冬胰岛素在妊娠糖尿病治疗中的应用研究

Application Study on Insulin Aspart in the Treatment of Gestational Diabetes

目的探究妊娠糖尿病患者采用门冬胰岛素治疗的具体方法和效果。方法选取2013年12月∽2014年9月收治的39例妊娠糖尿病患者进行治疗,随机分组,实验组22例采用门冬胰岛素的治疗,对照组17例患者选择生物合成人胰岛素的治疗,对比两组患者治疗后身体情况的变化。结果两组患者治疗后的餐前血糖、餐后1小时血糖以及糖化血红蛋白虽然实验组均好于对照组,但差异并不明显,无统计学意义（P〉0.05）。而血糖的达标时间、胰岛素的日用量以及低血糖的发生率,实验组均好于对照组,差异有统计学意义（P〈0.05）。结论妊娠糖尿病患者采用门冬胰岛素治疗,可在短时间内将血糖控制在正常范围内,而且使用时间段很少出现低血糖等并发症。

Objective To explore clinical method and effects of insulin aspart in the treatment of gestational diabetes. Methods 39 patients with gestational diabetes from December 2013 to September 2014 in our hospital were selected into control group and study group randomly, 22 patients in study group were given insulin aspart treatment and 17 patients in control group were given biosynthetic human insulin treatment. The patients＇ physical changes between two groups after treatment were compared. Results The blood glucose before dinner, one hour after dinner and glycated hemoglobin in study group were better than control group, however, the differences were not significant（P〈0.05）. While the recovering time of blood glucose, daily dosage of insulin and hypoglycemia incidence in study group were better than control group significantly（P〈0.05）. Conclusion Insulin aspart in the treatment of gestational diabetes can keep blood sugar normally in a short time, with few hypoglycemia complications.